Cargando…

A Novel Identified Peptide Hormone “Metabolitin” Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway

AIM: The purpose of this study was to explore the effect of a novel identified peptide hormone “metabolitin” on lipid absorption in the small intestine of mice with type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) and potential mechanisms. METHODS: T2DM was induced in mic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Peng, Wang, Shanjuan, Pang, Dongyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492287/ https://www.ncbi.nlm.nih.gov/pubmed/34621326 http://dx.doi.org/10.1155/2021/8386848

Ejemplares similares

Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism
por: Villar, Beatriz, et al.
Publicado: (2021)

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
por: Mohamed, Amal A, et al.
Publicado: (2022)

SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway
por: Kim, Da Eun, et al.
Publicado: (2020)

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway
por: Yu, Peng, et al.
Publicado: (2019)

MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
por: Sun, Hao, et al.
Publicado: (2023)

Neurotensin Agonist Attenuates Nicotine Potentiation to Cocaine Sensitization
por: Fredrickson, Paul, et al.
Publicado: (2014)

Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity
por: Barchetta, Ilaria, et al.
Publicado: (2018)

Endomorphin-2- and Neurotensin- Based Chimeric Peptide Attenuates Airway Inflammation in Mouse Model of Nonallergic Asthma
por: Russjan, Ewelina, et al.
Publicado: (2019)

On the relationship between glucose absorption and glucose‐stimulated secretion of GLP‐1, neurotensin, and PYY from different intestinal segments in the rat
por: Kuhre, Rune E., et al.
Publicado: (2017)

Fucoxanthin Attenuates Free Fatty Acid-Induced Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism/Oxidative Stress/Inflammation via the AMPK/Nrf2/TLR4 Signaling Pathway
por: Ye, Jiena, et al.
Publicado: (2022)

Asprosin contributes to nonalcoholic fatty liver disease through regulating lipid accumulation and inflammatory response via AMPK signaling
por: Zhang, Bo, et al.
Publicado: (2023)

A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties
por: Lee, Hee-Kyoung, et al.
Publicado: (2015)

Growth hormone and nonalcoholic fatty liver disease
por: Ma, Ingrid L., et al.
Publicado: (2023)

Imaging Neurotensin Receptor in Prostate Cancer With (64)Cu-Labeled Neurotensin Analogs
por: Deng, Huaifu, et al.
Publicado: (2017)

Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway
por: Zheng, Tao, et al.
Publicado: (2018)

A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo
por: Yan, Chenghui, et al.
Publicado: (2021)

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
por: Jang, Hyun-Jun, et al.
Publicado: (2023)

Neurotensin Attenuates Nociception by Facilitating Inhibitory Synaptic Transmission in the Mouse Spinal Cord
por: Zhang, Ming-Ming, et al.
Publicado: (2021)

Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease
por: Rao, Shenzong, et al.
Publicado: (2019)

The Anti-Apoptotic Role of Neurotensin
por: Devader, Christelle, et al.
Publicado: (2013)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Neurotensin Branched Peptide as a Tumor-Targeting Agent for Human Bladder Cancer
por: Brunetti, Jlenia, et al.
Publicado: (2015)

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
por: Ma, Yuting, et al.
Publicado: (2022)

Endogenous CNS Expression of Neurotensin and Neurotensin Receptors Is Altered during the Postpartum Period in Outbred Mice
por: Driessen, Terri M., et al.
Publicado: (2014)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Yang, Meng, et al.
Publicado: (2021)

Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2
por: Bodin, Sacha, et al.
Publicado: (2023)

Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
por: Li, Chun-Xiao, et al.
Publicado: (2019)

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
por: Augustyn, Monika, et al.
Publicado: (2019)

Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Liu, Lu, et al.
Publicado: (2023)

Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure–Activity Relationship Studies
por: Gonzalez, Simon, et al.
Publicado: (2020)

Neurotensin contributes to pediatric intestinal failure-associated liver disease via regulating intestinal bile acids uptake
por: Xiao, Yongtao, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease
por: Wen, Shuai, et al.
Publicado: (2022)

Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK–IDH2 pathway
por: Huang, Hao, et al.
Publicado: (2023)

Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice
por: Ke, Zunli, et al.
Publicado: (2023)

Thermostabilisation of the neurotensin receptor NTS1
por: Shibata, Yoko, et al.
Publicado: (2009)

Structure of the agonist-bound neurotensin receptor
por: White, Jim F., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n2fafvs06oud1bojsj4pha2ge3